Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


05.02.2024

2 Acta Neuropathol
2 Alzheimer Dis Assoc Disord
10 Alzheimers Dement
3 Ann Neurol
1 BMJ
1 Brain
2 Brain Res
3 Curr Alzheimer Res
1 Exp Gerontol
16 J Alzheimers Dis
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
2 Nat Med
3 Nature
1 Neurobiol Dis
3 Neurochem Res
1 Neurology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. AGUERO C, Dhaynaut M, Amaral AC, Moon SH, et al
    Head-to-head comparison of [(18)F]-Flortaucipir, [(18)F]-MK-6240 and [(18)F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases.
    Acta Neuropathol. 2024;147:25.
    PubMed         Abstract available

  2. LEITNER D, Pires G, Kavanagh T, Kanshin E, et al
    Similar brain proteomic signatures in Alzheimer's disease and epilepsy.
    Acta Neuropathol. 2024;147:27.
    PubMed         Abstract available


    Alzheimer Dis Assoc Disord

  3. FREDERIKSEN KS, Morato X, Zetterberg H, Gauthier S, et al
    Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000600.
    PubMed         Abstract available

  4. D'SOUZA GM, Churchill NW, Guan DX, Khoury MA, et al
    Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000607.
    PubMed         Abstract available


    Alzheimers Dement

  5. FREEZE WM, Van Veluw SJ, Jansen WJ, Bennett DA, et al
    Locus coeruleus pathology is associated with cerebral microangiopathy at autopsy.
    Alzheimers Dement. 2023;19:5023-5035.
    PubMed         Abstract available

  6. RUBINSTEIN T, Brickman AM, Cheng B, Burkett S, et al
    Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13683.
    PubMed         Abstract available

  7. GOMEZ-ARBOLEDAS A, Fonseca MI, Kramar E, Chu SH, et al
    C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13682.
    PubMed         Abstract available

  8. HUBER H, Blennow K, Zetterberg H, Boada M, et al
    Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.
    Alzheimers Dement. 2024 Jan 29. doi: 10.1002/alz.13697.
    PubMed         Abstract available

  9. ALGECIRAS-SCHIMNICH A, Bornhorst JA
    Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers.
    Alzheimers Dement. 2024 Jan 30. doi: 10.1002/alz.13721.
    PubMed        


  10. Withdrawal: Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13724.
    PubMed         Abstract available

  11. DAMSGAARD L, Janbek J, Laursen TM, Hogh P, et al
    Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13681.
    PubMed         Abstract available

  12. ROSSANO SM, Johnson AS, Smith A, Ziaggi G, et al
    Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13699.
    PubMed         Abstract available

  13. SHAABAN CE, Lin HS, Terry M, Ren D, et al
    COVID-19 pandemic's relationship with enrollment at US Alzheimer's Disease Research Centers.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13706.
    PubMed         Abstract available

  14. GRIFFIN JM, Kim K, Finnie DM, Lapid MI, et al
    Developing and describing a typology of lucid episodes among people with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Feb 2. doi: 10.1002/alz.13667.
    PubMed         Abstract available


    Ann Neurol

  15. SALTIEL N, Tripodis Y, Menzin T, Olaniyan A, et al
    Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts.
    Ann Neurol. 2024;95:314-324.
    PubMed         Abstract available

  16. KUCHENBECKER LA, Tipton PW, Martens Y, Brier MR, et al
    Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia.
    Ann Neurol. 2024;95:299-313.
    PubMed         Abstract available

  17. CHEN X, Toueg TN, Harrison TM, Baker SL, et al
    Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Ann Neurol. 2024;95:249-259.
    PubMed         Abstract available


    BMJ

  18. DYER O
    Aduhelm: Biogen abandons Alzheimer's drug after controversial approval left it unfunded by Medicare.
    BMJ. 2024;384:q281.
    PubMed        


    Brain

  19. AHMED H, Wang Y, Griffiths WJ, Levey AI, et al
    Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.
    Brain. 2024 Feb 1:awae028. doi: 10.1093.
    PubMed         Abstract available


    Brain Res

  20. TSAMOU M, Roggen EL
    Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).
    Brain Res. 2024 Jan 31:148791. doi: 10.1016/j.brainres.2024.148791.
    PubMed         Abstract available

  21. LANDIN-ROMERO R, Kumfor F, Ys Lee A, Leyton C, et al
    Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
    Brain Res. 2024;1829:148777.
    PubMed         Abstract available


    Curr Alzheimer Res

  22. DING Q, Lamberts J, Konieczny AM, Bringedahl TB, et al
    Association of Autoimmune Disorders and Disease-modifying Antirheumatic Drugs with the Risk of Alzheimer's and/or Dementia: A Population Study Using Medicare Beneficiary Data.
    Curr Alzheimer Res. 2024 Jan 26. doi: 10.2174/0115672050289966240110041616.
    PubMed         Abstract available

  23. STOVER KR, Stafford PM, Damian AC, Pasangulapati JP, et al
    Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Jan 26. doi: 10.2174/0115672050283199240111111801.
    PubMed         Abstract available

  24. SHIM YS
    Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Abeta: A Pilot Study.
    Curr Alzheimer Res. 2024 Jan 30. doi: 10.2174/0115672050284054240119101834.
    PubMed         Abstract available


    Exp Gerontol

  25. XUE H, Chen J, Zeng L, Fan W, et al
    Causal relationship between circulating immune cells and the risk of Alzheimer's disease: A Mendelian randomization study.
    Exp Gerontol. 2024 Jan 30:112371. doi: 10.1016/j.exger.2024.112371.
    PubMed         Abstract available


    J Alzheimers Dis

  26. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
    Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2023;95:1417-1425.
    PubMed         Abstract available

  27. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
    Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
    PubMed         Abstract available

  28. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
    Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
    PubMed         Abstract available

  29. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
    PubMed         Abstract available

  30. WHEELER KV, Irimia A, Braskie MN
    Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
    PubMed         Abstract available

  31. DE LA MONTE SM, Tong M
    Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
    PubMed         Abstract available

  32. NOORI A, Jayakumar R, Moturi V, Li Z, et al
    Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
    PubMed         Abstract available

  33. SIBLE IJ, Nation DA
    Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
    PubMed         Abstract available

  34. LI J, Yang M, Wei R, Cao Y, et al
    The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
    PubMed         Abstract available

  35. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
    Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
    PubMed         Abstract available

  36. JIAO L, Jing Z, Zhang W, Su X, et al
    Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
    PubMed         Abstract available

  37. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
    Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
    PubMed         Abstract available

  38. MONE P, De Luca A, Kansakar U, Santulli G, et al
    Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
    PubMed         Abstract available

  39. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
    The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
    J Alzheimers Dis. 2024;97:1007-1031.
    PubMed         Abstract available

  40. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
    The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
    J Alzheimers Dis. 2024;97:1353-1363.
    PubMed         Abstract available

  41. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
    Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
    J Alzheimers Dis. 2024;97:1111-1123.
    PubMed         Abstract available


    J Neurol

  42. SUBOTIC A, Gee M, Nelles K, Ba F, et al
    Gray matter loss relates to dual task gait in Lewy body disorders and aging.
    J Neurol. 2024;271:962-975.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  43. PATEL V, Edison P
    Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 30:jnnp-2023-332661.
    PubMed         Abstract available


    J Neurosci

  44. NIRAULA S, Yan SS, Subramanian J
    Amyloid Pathology Impairs Experience-Dependent Inhibitory Synaptic Plasticity.
    J Neurosci. 2024;44:e0702232023.
    PubMed         Abstract available


    Nat Med

  45. JUCKER M, Walker LC
    Evidence for iatrogenic transmission of Alzheimer's disease.
    Nat Med. 2024 Jan 29. doi: 10.1038/s41591-023-02768.
    PubMed        

  46. BANERJEE G, Farmer SF, Hyare H, Jaunmuktane Z, et al
    Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone.
    Nat Med. 2024 Jan 29. doi: 10.1038/s41591-023-02729.
    PubMed         Abstract available


    Nature

  47. WONG C
    Signs of 'transmissible' Alzheimer's seen in people who received growth hormone.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00268.
    PubMed        

  48. GRAHAM F
    Daily briefing: Drugs such as Ozempic could help with Alzheimer's and Parkinson's.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00272.
    PubMed        

  49. KRAMER K
    Daily briefing: New evidence supports controversial hypothesis of 'transmissible' Alzheimer's.
    Nature. 2024 Jan 30. doi: 10.1038/d41586-024-00282.
    PubMed        


    Neurobiol Dis

  50. KOURTI M, Metaxas A
    A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease.
    Neurobiol Dis. 2024 Jan 31:106427. doi: 10.1016/j.nbd.2024.106427.
    PubMed         Abstract available


    Neurochem Res

  51. LIU Y, Meng XK, Shao WZ, Liu YQ, et al
    miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise.
    Neurochem Res. 2024 Jan 30. doi: 10.1007/s11064-024-04108.
    PubMed         Abstract available

  52. DHALIWAL N, Dhaliwal J, Chopra K
    7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia.
    Neurochem Res. 2024 Feb 1. doi: 10.1007/s11064-023-04090.
    PubMed         Abstract available

  53. ZHANG LJ, Zhang HZ, Liu YW, Tang M, et al
    Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
    Neurochem Res. 2024 Feb 2. doi: 10.1007/s11064-024-04107.
    PubMed         Abstract available


    Neurology

  54. PASE MP, Himali JJ, Puerta R, Beiser AS, et al
    Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia.
    Neurology. 2024;102:e208075.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.